Literature DB >> 12675212

Drug-HPMA-HuIg conjugates effective against human solid cancer.

Blanka Ríhová1, Jirí Strohalm, Katerina Kubácková, Markéta Jelínková, Ladka Rozprimová, Milada Sírová, Dana Plocová, Tomás Mrkvan, Marek Kovár, Jindriska Pokorná, Tomás Etrych, Karel Ulbrich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12675212     DOI： 10.1007/0-306-47932-x_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  4 in total

1.  A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas.

Authors:  Cameron C Lee; Elizabeth R Gillies; Megan E Fox; Steven J Guillaudeu; Jean M J Fréchet; Edward E Dy; Francis C Szoka
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

2.  Preclinical evaluation of linear HPMA-doxorubicin conjugates with pH-sensitive drug release: efficacy, safety, and immunomodulating activity in murine model.

Authors:  Milada Sirova; Tomas Mrkvan; Tomas Etrych; Petr Chytil; Pavel Rossmann; Marketa Ibrahimova; Lubomir Kovar; Karel Ulbrich; Blanka Rihova
Journal:  Pharm Res       Date:  2009-11-06       Impact factor: 4.200

3.  Starlike vs. classic macromolecular prodrugs: two different antibody-targeted HPMA copolymers of doxorubicin studied in vitro and in vivo as potential anticancer drugs.

Authors:  Markéta Jelínková; Jirí Strohalm; Tomás Etrych; Karel Ulbrich; Blanka Ríhová
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

4.  Integrin Targeted MR Imaging.

Authors:  Mingqian Tan; Zheng-Rong Lu
Journal:  Theranostics       Date:  2011-01-19       Impact factor: 11.556
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.